Skip to content

Role of Homoeopathic medicine in the treatment of Allergic Rhinitis (Common Cold)

The Role of Homoeopathic Prescription Based on Concomitant Symptoms Versus Presenting Complaints in Management of Allergic Rhinitis â?? A Comparative Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050544
Enrollment
65
Registered
2023-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic Medicine based on concomitant symptoms: Oral route of administration pill form 30 pill size centesimal scale First dose during baseline treatment. Repetiton according to f

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient diagnosed with Allergic Rhinitis symptoms that are sneezing, itching, rhinorrhea, and nasal congestion, generally at night with nasal obstruction, sleep disturbances. 2) Patients who had taken any Anti â?? allergic medicines for Allergic Rhinitis after wash-out period of 2 weeks.

Exclusion criteria

Exclusion criteria: 1.) Patient with other Upper respiratory tract infection (Laryngitis, Pharyngitis, Diphtheria, Etc.) 2.) Patient with Lower respiratory tract infection (Chronic bronchitis, Bronchial Asthma, Pulmonary Tuberculosis). 3) Exclusion criteria consisted of gross nasal developmental defects or structural abnormalities causing obstruction, e.g., nasal polyp(s), deviated septum etc. 4.) Patient on steroid treatment. 5.) Pregnant and Lactating female.

Design outcomes

Primary

MeasureTime frame
Difference in scoring before and after treatment using TNSS scale (include any appropriate measures of nasal congestion, runny nose, nasal itching, sneezing and difficult sleep) considering change of 11 â?? 15 score to be mild improvement, change of 6 â?? 10 is considered to be moderate improvement, change of 0 â?? 5 to be considered as marked improvement Timepoint: TNSS Scale to be used at baseline, 4 weeks, 8 weeks, 12 weeks etc

Secondary

MeasureTime frame
To assess the change in WHOQOL â?? BREF Scale in pre and post treatment. In this the maximum score is 130. A score from 0 -25 is considered to be very poor, from 26 â?? 51 is considered to be poor, from 52 â?? 77 is considered to be Neither poor nor good, from 78 â?? 103 is considered to be good, from 104 â?? 130 is considered to be very good.Timepoint: WHO QOL to be used every 4 weeks, 8 weeks, 12 weeks etc

Countries

India

Contacts

Public ContactDr Rashid Akhtar

Bakson Homoeopathic Medical College and Hospital

drashitagupta06@gmail.com8376964477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026